DRUG

Exendin-4

1 hypothesis across 1 therapeutic domain

ALL HYPOTHESES

Repurposing candidates for Exendin-4

Pancreatic cancer 1

Mediator Outcome Score Tier Lit. status Trial
GLP-1R pancreatic ductal adenocarcinoma 0.230 Mid novel signal none

Clinical trials

200 registered trials for Exendin-4

Source: ClinicalTrials.gov

← All drugs